NeuroSense Therapeutics Ltd. (NRSN) Operating income 2021–2025
NeuroSense Therapeutics Ltd. (NRSN) annual operating income history from SEC filings — each fiscal year as reported.
-$11.1MFY2025 · since FY2021: -$3.0M → -$11.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.1M | -11.9% |
| FY2024 | -$9.9M | +17.8% |
| FY2023 | -$12.0M | -14.2% |
| FY2022 | -$10.6M | -253.6% |
| FY2021 | -$3.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NRSN financial trends
NRSN RevenueNRSN Net incomeNRSN Net marginNRSN Gross profitNRSN Gross marginNRSN Operating marginNRSN Operating cash flowNRSN Free cash flowNRSN Capital expendituresNRSN Return on equityNRSN Stock buybacksNRSN Dividends paidNRSN Total assetsNRSN Total liabilitiesNRSN Shareholders’ equityNRSN overview →